Alpha 2.0
Login Register
» Authors » Daniela Kroshinsky

Daniela Kroshinsky

Explore the profile of Daniela Kroshinsky including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 185
Citations 1952
Followers 0
Related Specialties
Dermatology
General Medicine
Pediatrics
Top 10 Co-Authors
Sagar U Nigwekar
Mai P Hoang
Lauren N Ko
Jessica St John
Renajd Rrapi
Radhika Shah
Sidharth Chand
Colleen K Gabel
Allison S Dobry
Priyanka Vedak
Published In
J Am Acad Dermatol
JAMA Dermatol
Pediatr Dermatol
Dermatopathology (Basel)
JAAD Case Rep
Affiliations
Soon will be listed here.
Recent Articles
1.
Drug Reaction with Eosinophilia and Systemic Symptoms. Reply
Blumenthal K, Cardones A, Kroshinsky D
N Engl J Med . 2025 Feb; 392(9):935. PMID: 40009822
No abstract available.
2.
Drug Reaction with Eosinophilia and Systemic Symptoms
Kroshinsky D, Cardones A, Blumenthal K
N Engl J Med . 2024 Dec; 391(23):2242-2254. PMID: 39665653
No abstract available.
3.
Clinical manifestations of drug reaction with eosinophilia and systemic symptoms in pediatric patients
Blackley S, Lemoine-Soto C, Zhou L, Ezeofor A, Lo Y, Blumenthal K, et al.
JAAD Case Rep . 2024 Nov; 53:163-166. PMID: 39555309
No abstract available.
4.
Case 22-2024: A Woman with Postpartum Fever, Abdominal Pain, and Skin Ulcers. Reply
Merola J, Kwan M, Kroshinsky D
N Engl J Med . 2024 Oct; 391(17):1663. PMID: 39476357
No abstract available.
5.
Inpatient Management of Hidradenitis Suppurativa: A Delphi Consensus Study
Needham M, Pichardo R, Alavi A, Chang A, Daveluy S, DeNiro K, et al.
Cutis . 2024 Jul; 113(6):251-254. PMID: 39082985
Inpatient hospitalization of individuals with hidradenitis suppurativa (HS) has increased. Inpatient services may not be familiar enough with this disease to understand how to manage severe HS and/or HS flares....
6.
Case 22-2024: A 30-Year-Old Woman with Postpartum Fever, Abdominal Pain, and Skin Ulcers
Merola J, Cochran R, Kroshinsky D, Prabhu M, Kwan M
N Engl J Med . 2024 Jul; 391(3):260-271. PMID: 39018536
No abstract available.
7.
Assessment of diagnostic delay, morbidity, and mortality outcomes in 302 calciphylaxis patients over a 17-year period: A retrospective cohort study
Tan A, Xia J, Glennon C, Locascio J, Gabel C, Nguyen E, et al.
J Am Acad Dermatol . 2024 Jul; 91(5):834-842. PMID: 38972479
Background: Calciphylaxis patients historically have experienced diagnostic challenges and high morbidity; however limited data is available examining these characteristics over time. Objective: The primary goals were to a) investigate factors...
8.
Sweet syndrome in pregnancy: A narrative review
Glennon C, Tan A, Prabhu M, Kroshinsky D
Int J Gynaecol Obstet . 2024 Jun; 166(2):538-550. PMID: 38881204
The aim of this review is to increase obstetrician awareness of pregnancy-associated Sweet syndrome. Patients present with fever, leukocytosis, and skin eruption, which can mimic other infectious or inflammatory conditions,...
9.
Understanding the patient experience of drug reaction with eosinophilia and systemic symptoms: A qualitative study
Samarakoon U, Wolfson A, Zhou L, Bassir F, Phillips E, Kroshinsky D, et al.
J Am Acad Dermatol . 2024 Apr; 91(2):370-373. PMID: 38677336
No abstract available.
10.
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy
Chen S, Semenov Y, Alloo A, Bach D, Betof Warner A, Bougrine A, et al.
J Immunother Cancer . 2024 Apr; 12(4). PMID: 38599660
With an increasing number of patients eligible for immune checkpoint inhibitors, the incidence of immune-related adverse events (irAEs) is on the rise. Dermatologic immune-related adverse events (D-irAEs) are the most...